Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Europe entities : Dynavax technologies corporation save search
European Commission Approves Purchase Agreement Amendment for Valneva’s Inactivated COVID-19 Vaccine
Published: 2022-07-20 (Crawled : 20:00) - biospace.com/
DVAX | $11.69 -1.27% -1.28% 1.9M
|
Health Technology
|
| O: 0.41%
H: 6.09%
C: 3.7%
covid-19 vaccine agreement
Valneva Receives Marketing Authorization in Europe for Inactivated Whole-Virus COVID-19 Vaccine VLA2001
Published: 2022-06-24 (Crawled : 17:00) - globenewswire.com
DVAX | $11.69 -1.27% -1.28% 1.9M
|
Health Technology
|
| O: -0.65%
H: 1.52%
C: 1.07%
covid-19 valneva europe vaccine vla2001 authorization
Valneva Receives Positive CHMP Opinion for Marketing Authorization of its Inactivated COVID-19 Vaccine Candidate in Europe
Published: 2022-06-23 (Crawled : 13:20) - globenewswire.com
DVAX | $11.69 -1.27% -1.28% 1.9M
|
Health Technology
|
| O: 0.52%
H: 6.31%
C: 6.23%
covid-19 valneva europe candidate chmp vaccine authorization positive
EMA Accepts Filing of Marketing Authorization Application for Valneva’s Inactivated COVID-19 Vaccine Candidate
Published: 2022-05-19 (Crawled : 07:00) - biospace.com/
DVAX | $11.69 -1.27% -1.28% 1.9M
|
Health Technology
|
| O: 1.38%
H: 17.99%
C: 16.95%
covid-19 vaccine ema application authorization
Valneva’s Inactivated COVID-19 Vaccine Candidate Shown to Neutralize Omicron Variant
Published: 2022-01-19 (Crawled : 18:00) - biospace.com/
DVAX | $11.69 -1.27% -1.28% 1.9M
|
Health Technology
|
| O: 0.67%
H: 3.55%
C: -0.66%
covid-19 valneva covid vaccine
Valneva Confirms Clinical Trial and Regulatory Submission Timelines for its Inactivated COVID-19 Vaccine Candidate VLA2001
Published: 2022-01-06 (Crawled : 10:00) - biospace.com/
DVAX | $11.69 -1.27% -1.28% 1.9M
|
Health Technology
|
| O: 4.52%
H: 7.13%
C: -0.53%
covid-19 valneva trial covid vla200 vaccine vla2001 submission
Valneva Signs Purchase Agreement with European Commission for its Inactivated COVID-19 Vaccine VLA2001
Published: 2021-11-23 (Crawled : 18:00) - globenewswire.com
DVAX | $11.69 -1.27% -1.28% 1.9M
|
Health Technology
|
| O: -0.37%
H: 1.67%
C: -2.47%
vla200 covid valneva europe vaccine vla2001 covid-19
Valneva Announces European Commission Approval of Advance Purchase Agreement for up to 60 Million Doses of Inactivated COVID-19 Vaccine VLA2001
Published: 2021-11-10 (Crawled : 12:00) - globenewswire.com
DVAX | $11.69 -1.27% -1.28% 1.9M
|
Health Technology
|
| O: 0.55%
H: 3.04%
C: -2.91%
covid europe vaccine vla2001 approval
Gainers vs Losers
| 49% | 51% |
Top 10 Gainers
KAVL | $6.275 135.02% 57.45% 44M
|
Wholesale Trade
PXMD | $0.7375 79.09% 44.16% 4.5M
|
Health Technology
DYNT | $0.371 -5.12% 43.09% 3.3M
|
Health Technology
LGVN P 3 d | $2.94 73.96% 42.52% 57M
|
HUBC | $1.94 49.23% 32.99% 73M
|
n/a
SPCB | $0.4044 46.52% 31.75% 130M
|
Electronic Technology
ONVO | $1.34 32.66% 24.62% 54M
|
Health Technology
OMQS | $0.6869 32.1% 24.3% 3.6M
|
Professional, Scientific, and T...
SNPO | $10.555 29.67% 22.88% 4M
|
AMBI | $3.72 -26.77% 21.77% 9.8K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.